OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Company News Release
For the second consecutive year, Quintiles has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress now under way in Washington, D.C., the awards recognize and celebrate individuals, organizations and initiatives which have made significant contributions over the past 12 months.
The Best CRO award is presented to the honored CRO following two rounds of evaluation. First, customers vote for their preferred CRO online prior to the World Vaccine Congress to arrive at a list of five companies per category. Then, a judging panel makes its selection based on information provided in the following criteria:
“We’re proud to be recognized by our customers and peers as the Best CRO,” said Dr. Christopher Cabell, senior vice president, Therapeutic Delivery Unit. “We work every day to advance the development of quality vaccines and anti-infective products. This achievement celebrates our commitment to create a healthier world.”
Two Quintiles scientific and operational experts presented as part of the technical seminars offered at the World Vaccine Congress.
Quintiles helped develop or commercialize 73% (11 of 15) of 2011’s best selling Vaccine products or compounds.
For more news on vaccines in clinical trials, check out the edition of ACT Direct e-news that went out this morning.
Related Content:
News